Jagran Josh Logo

EU lifted ban imposed on drug exports from Ranbaxy’s Toansa Plant

Jun 6, 2014 17:33 IST

The European health regulator on 5 June 2014 lifted suspension imposed on export of drugs produced at the Ranbaxy’s Toansa plant in Punjab in India. The imposed ban was lifted by terming that the medicines produced at the site don’t pose any threat to public health despite having number of manufacturing deficiencies.

The European Medicines Agency (EMA) announced that assessment of reported non-compliance with Good Manufacturing Practice (GMP) at Ranbaxy Laboratories at Toansa, India has been finalised by the European regulatory authorities. The assessment showed a number of GMP deficiencies at the concerned site, but doesn’t pose any threat to public health.

Based on the assessment report of the regulatory authorities, the GMP certificate of the plant will be reinstated which was suspended in January 2014 in European Union. The certificate will be re-entered into EudraGMDP, the EU database that contains GMP certificates.

Is this article important for exams ? Yes23 People Agreed

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

Newsletter Signup
Follow us on
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK